Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes

Human Molecular Genetics

Volumn 6, Issue 13, 1997, Pages 2309-2315

  Vehmanen, Paula ^a   Friedman, Lori S ^b   Eerola, Hannaleena ^a   McClure, Melody ^c   Ward, Brian ^c   Sarantaus, Laura ^a   Kainu, Tommi ^d   Syrjäkoski, Kirsi ^d   Pyrhönen, Seppo ^a   Kallioniemi, Olli P ^d   Muhonen, Timo ^a   Luce, Michael ^c   Frank, Thomas S ^c   Nevanlinna, Heli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c Utah   (United States)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER FAMILY; CANCER SUSCEPTIBILITY; CHROMOSOME 13Q; CHROMOSOME 17Q; CONTROLLED STUDY; DELETION MUTANT; FEMALE; FINLAND; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 9844239380     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.13.2309     Document Type: Article

References (36)

1. Newman, B., Austin, M.A., Lee, M. and King, M.-C. (1988) Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. Proc. Natl Acad. Sci. USA, 85, 3044-3048.
2. Claus, E.B., Risch, N. and Thompson, W.D. (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet., 48, 232-242.
3. Hall, J.M., Lee, M.K., Newman, B., Morrow, J.E., Anderson, L.A., Huey, B.and King, M.-C. (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250, 1684-1689.
4. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S, Liu, Q., et al. (1994) A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
5. Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y, Ford, D., Collins, N., Nguyen, K., et al. (1994) Localization of a breast-cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265, 2088-2090.
6. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.
7. Tavtigian, S.V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., et al. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet., 12, 333-337.
8. Easton, D.F., Bishop, D.T., Ford, D., Crockford, G.P. and the Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am. J. Hum. Genet., 52, 678-701.
9. Szabo, C.I. and King, M.-C. (1997) Population genetics of BRCAI and BRCA2. Am. J. Hum. Genet., 60, 1013-1020.
10. Gudmundsson, J., Johannesdottir, G., Arason, A., Bergthorsson, J.T., Ingvarsson, S., Egilsson, V.and Bjork Barkardottir, R. (1996) Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am. J. Hum. Genet., 58, 749-756.
11. Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J.G., Tavtigian, S.V., Tulinius, H., et al. (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nature Genet., 13, 117-119.
12. Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Brody, L.C., Kaback, M., Haas, B., et al. (1996) The carrier frequency of the BRCA2 6174delT mutation in Ashkenazi Jewish individuals is approximately 1%. Nature Genet., 14, 188-190.
13. Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S. (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet., 14, 185-187.
14. Struewing, J.P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M.K., Collins, F.S.and Brody, L.C. (1996) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet., 11, 198-200.
15. de la Chapelle, A. (1993) Disease gene mapping in isolated human populations: the example of Finland. J. Med. Genet., 30, 857-865.
16. Vehmanen, P., Friedman, L.S., Eerola, H., Sarantaus, L., Pyrhönen, S., Ponder, B., Muhonen, T, and Nevanlinna, H. (1997) A low proportion of BRCA2 mutations in Finnish breast cancer families. Am. J. Hum. Genet., 60, 1050-1058.
17. Shapiro, M.B. and Senapathy, P. (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res., 15, 7155-7175.
18. Friend, S. and the Breast Cancer Information Core Steering Committee (1995) Breast cancer information on the web. Nature Genet., 11, 238-239.
19. Auranen, A., Pukkala, E., Mäkinen, J., Sankila, R., Grenman, S. and Salmi, T. (1996) Cancer incidence in the first-degree relatives of ovarian cancer patients. Br. J. Cancer, 74, 280-284.
20. Peelen, T., van Vliet, M., Petrij-Bosch, A., Mieremet, R., Szabo, C., van den Ouweland, A.M.W., Hogervorst, F., et al. (1997) A high proportion of novel mutations in BRCA1 with strong founder effect among Dutch and Belgian hereditary breast and ovarian cancer families. Am. J. Hum. Genet., 60, 1041-1049.
21. Gayther, S., Harrington, P., Russel, P., Kharkevich, G., Garkartseva, R.F. and Ponder, B.A.J. (1997) Frequently occurring germ line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet., 60, 1239-1242.
22. Ramus, S.J., Kote-Jarai, Z., Friedman, L.S., van der Looji, M., Gayther, S., Csokay, B., Ponder, B.A.J. and Olah, E. (1997) Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast/ovarian cancer. Am. J. Hum. Genet., 60, 1242-1246.
23. Neuhausen, S.L., Mazoyer, S., Friedman, L., Stratton, M., Offit, K., Caligo, A., Tomlinsoin, G., et al. (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am. J. Hum. Genet., 58, 271-280.
24. Schubert, E.L., Lee, M.K., Mefford, H.C., Argonza, R.H., Morrow, J.E., Hull, J., Dann, J.L. and King, M.C. (1997) BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 and BRCA2. Am. J. Hum. Genet., 60, 1031-1040.
25. Krainer, M., Silva-Arrieta, S., FitzGerald, M., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D.J., et al. (1997) Differential contributions of BRCA1 and BRCA2 to early onset breast cancer N. Engl. J. Med., 336, 1416-1421.
26. Gayther, S.A., Warren, W., Mazoyer, S., Russel, P.A., Harrington, P.A., Chiano, M., Seal, S., et al. (1995) Germline mutations of the BRCAI gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet., 11, 428-433.
27. Cotton, R.G.H. (1993) Current methods of mutation detection. Mutation Res., 285, 125-144.
28. Håkansson, S., Johansson, O., Johansson, U., Sellberg, G., Loman, N., Gerdes, A.-M., Holmberg, E., et al. (1997) Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet., 60, 1068-1078.
29. Phelan, C.M., Lancaster, J.M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., et al. (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet., 13, 120-122.
30. Serova, O., Mazoyer, S., Puget, N., Dubois, V, Tonin, P., Shugart, Y.Y., Goldgar, D., et al. (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am. J. Hum. Genet., 60, 486-495.
31. Rebbeck, T.R., Couch, F.J., Kant, J., Calzone, K., DeShano, M., Peng. Y., Chen, K., et al. (1996) Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am. J. Hum. Genet., 59, 547-553.
32. Hogervorst, F.B.L., Cornelis, R.S., Bout, M., van Vliet, M., Oosterwijk, J.C., Olmer, R., Bakker, B., et al. (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet., 10, 208-212.
33. Friedman, L.S., Gayther, S.A., Kurosaki, T, Gordon, D., Noble, B., Casey, G., Ponder, B.A.J.and Anton-Culver, H. (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum Genet., 60, 313-319.
34. Friedman, L.S., Szabo, C.I., Ostermeyer, E.A., Dowd, P., Butler, L., Park, T., Lee, M.K., et al. (1995) Novel inherited mutations and variable expressivity of BRCAI alleles, including the founder mutation in Ashkenazi Jewish families. Am. J. Hum. Genet., 57, 1284-1297.
35. Hall, J.M., Friedman, L., Guenther, C, Lee, M.K., Weber, J.L., Black, D.M.and King, M.C. (1992) Closing in on a breast cancer gene on chromosome 17q. Am. J. Hum. Genet., 50, 1235-1242.
36. Couch, F.J., Rommens, J.M., Neuhausen, S.L., Belanger, C., Dumont, M., Abel, K., Bell, R., et al. (1996) Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics, 36, 86-99.